Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59


Donation, Not Disease! A Multiple-Hit Hypothesis on Development of Post-Donation Kidney Disease.

Cheng XS, Glassock RJ, Lentine KL, Chertow GM, Tan JC.

Curr Transplant Rep. 2017;4(4):320-326. doi: 10.1007/s40472-017-0171-8. Epub 2017 Nov 4. Review.


KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Lentine KL, Kasiske BL, Levey AS, Adams PL, AlberĂș J, Bakr MA, Gallon L, Garvey CA, Guleria S, Li PK, Segev DL, Taler SJ, Tanabe K, Wright L, Zeier MG, Cheung M, Garg AX.

Transplantation. 2017 Aug;101(8S Suppl 1):S1-S109. doi: 10.1097/TP.0000000000001769.


Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Lentine KL, Kasiske BL, Levey AS, Adams PL, AlberĂș J, Bakr MA, Gallon L, Garvey CA, Guleria S, Li PK, Segev DL, Taler SJ, Tanabe K, Wright L, Zeier MG, Cheung M, Garg AX.

Transplantation. 2017 Aug;101(8):1783-1792. doi: 10.1097/TP.0000000000001770. Review.


The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation.

Brifkani Z, Brennan DC, Lentine KL, Horwedel TA, Malone AF, Delos Santos R, Maw TT, Alhamad T.

Transplant Direct. 2017 Feb 8;3(3):e133. doi: 10.1097/TXD.0000000000000645. eCollection 2017 Mar.


Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study.

Dharnidharka VR, Schnitzler MA, Chen J, Brennan DC, Axelrod D, Segev DL, Schechtman KB, Zheng J, Lentine KL.

Transpl Int. 2016 Nov;29(11):1226-1236. doi: 10.1111/tri.12850. Epub 2016 Sep 28.


Understanding and Communicating Medical Risks for Living Kidney Donors: A Matter of Perspective.

Lentine KL, Segev DL.

J Am Soc Nephrol. 2017 Jan;28(1):12-24. doi: 10.1681/ASN.2016050571. Epub 2016 Sep 2. Review.


The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis.

Axelrod DA, Schnitzler MA, Xiao H, Naik AS, Segev DL, Dharnidharka VR, Brennan DC, Lentine KL.

Am J Transplant. 2017 Feb;17(2):377-389. doi: 10.1111/ajt.14018. Epub 2016 Oct 4.


Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation.

Alhamad T, Brennan DC, Brifkani Z, Xiao H, Schnitzler MA, Dharnidharka VR, Axelrod D, Segev DL, Lentine KL.

Transplantation. 2016 May;100(5):1086-93. doi: 10.1097/TP.0000000000001113.


Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims Data.

Lentine KL, Naik AS, Schnitzler M, Axelrod D, Chen J, Brennan DC, Segev DL, Kasiske BL, Randall H, Dharnidharka VR.

Transplant Proc. 2016 Jan-Feb;48(1):55-8. doi: 10.1016/j.transproceed.2015.12.024.


National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence-Based Regimen Selection.

Axelrod DA, Naik AS, Schnitzler MA, Segev DL, Dharnidharka VR, Brennan DC, Bae S, Chen J, Massie A, Lentine KL.

Am J Transplant. 2016 Aug;16(8):2453-62. doi: 10.1111/ajt.13758. Epub 2016 Mar 31.


Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients.

Axelrod D, Segev DL, Xiao H, Schnitzler MA, Brennan DC, Dharnidharka VR, Orandi BJ, Naik AS, Randall H, Tuttle-Newhall JE, Lentine KL.

Am J Transplant. 2016 May;16(5):1465-73. doi: 10.1111/ajt.13616. Epub 2016 Feb 8.


Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice.

Naik AS, Dharnidharka VR, Schnitzler MA, Brennan DC, Segev DL, Axelrod D, Xiao H, Kucirka L, Chen J, Lentine KL.

Transpl Int. 2016 Feb;29(2):241-52. doi: 10.1111/tri.12711. Epub 2015 Dec 9.


Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.

Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX; Chronic Kidney Disease Prognosis Consortium.

N Engl J Med. 2016 Feb 4;374(5):411-21. doi: 10.1056/NEJMoa1510491. Epub 2015 Nov 6.


Outcomes of Live Kidney Donors Who Develop End-Stage Renal Disease.

Muzaale AD, Massie AB, Kucirka LM, Luo X, Kumar K, Brown RS, Anjum S, Montgomery RA, Lentine KL, Segev DL.

Transplantation. 2016 Jun;100(6):1306-12. doi: 10.1097/TP.0000000000000920.


Erratum to: Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.

Lentine KL, Schnitzler MA, Xiao H, Brennan DC.

Trials. 2015 Sep 16;16:412. doi: 10.1186/s13063-015-0940-6. No abstract available.


Assessing Transplant Education Practices in Dialysis Centers: Comparing Educator Reported and Medicare Data.

Waterman AD, Peipert JD, Goalby CJ, Dinkel KM, Xiao H, Lentine KL.

Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1617-25. doi: 10.2215/CJN.09851014. Epub 2015 Aug 20.


Gender differences in use of prescription narcotic medications among living kidney donors.

Lentine KL, Lam NN, Schnitzler MA, Garg AX, Xiao H, Leander SE, Brennan DC, Taler SJ, Axelrod D, Segev DL.

Clin Transplant. 2015 Oct;29(10):927-37. doi: 10.1111/ctr.12599. Epub 2015 Sep 18.


Living Donor Kidney Transplantation: Improving Education Outside of Transplant Centers about Live Donor Transplantation--Recommendations from a Consensus Conference.

Waterman AD, Morgievich M, Cohen DJ, Butt Z, Chakkera HA, Lindower C, Hays RE, Hiller JM, Lentine KL, Matas AJ, Poggio ED, Rees MA, Rodrigue JR, LaPointe Rudow D; American Society of Transplantation.

Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1659-69. doi: 10.2215/CJN.00950115. Epub 2015 Jun 26.


Race, Relationship and Renal Diagnoses After Living Kidney Donation.

Lentine KL, Schnitzler MA, Garg AX, Xiao H, Axelrod D, Tuttle-Newhall JE, Brennan DC, Segev DL.

Transplantation. 2015 Aug;99(8):1723-9. doi: 10.1097/TP.0000000000000733.

Supplemental Content

Loading ...
Support Center